News
Bioibérica has had an event-filled month, with presentations of its newest products, SuzukiiTrap® and Crop-Scan®. Bioibéricas continued to callits Cera Trap® system the most efficient and eco-friendly mass trap device currently available in the national and international markets.
A Phase IV, randomized, double blind, placebo controlled clinical test was presented at the 21st National congress of the Spanish Society of Clinical pharmacology. The procedure consisted of applying a painful stimulus to the patients knees, then used functional magnetic resonance to measure the brains reaction to pain.
Recent studies have proved that osteoarthritis (OA) triples with the onset of menopause because of the decrease in estrogen levels. In many cases, it is the gynecologist who must identify the first symptoms of the disease.Today at Cordoba, the president of the 2nd GINEP scientific meeting, Dr. Santiago Palacios, will present Arthrotest the new DNA test that predicts the evolution of knee OA.
Now you can receive up to date news in the field of joint, digestive and immune system care. Easily, at all times and at all places, and for free.
The Spanish Rheumatology League and Bioibérica Farma have called upon healthcare authorities and the general population to meet the challenge poised by that disease; which currently affects seven million Spaniards.